There might not be a better place to find winning stocks that can slowly make you wealthy over decades than the healthcare ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with ...

When it comes to dividend investing, there are two basic paths you can take. If you can't decide which dividend investing ...

Analysts have mixed opinions on BMY, with a “Moderate Buy” consensus from 25 analysts. Seven rate it a “Strong Buy,” 17 recommend “Hold,” and one suggests “Sell.” The average price target is $59.52, ...

The two largest urban centres in the Northwest are Sligo, the county capital, and Letterkenny in Donegal. The total ...

Some prominent healthcare and consumer stocks have fallen out of favor with the market, so now is the time to pounce on some great deals.

WALTHAM, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: APLS) today announced that Keli Walbert will join the Apellis Board of Directors, effective immediately. Ms. Walbert brings more than two ...

Oxford, UK and San Jose, California, 9 January 2024 - Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of ...

After Abbott bought Knoll Pharmaceuticals, the division of BASF that developed Humira in 2000, the drug was approved in a range of inflammatory diseases . Now owned by AbbVie following a company ...